Plant ID: NPO1221
Plant Latin Name: Juniperus serawschanica
Taxonomy Genus: Juniperus
Taxonomy Family: Cupressaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
PPARA; PPARD; | |
TLR2; | |
ABCB1; | |
FABP3; LMNA; FABP2; FABP4; FABP5; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
ATP-binding cassette | ABCB1 | P-glycoprotein 1 | P08183 | CHEMBL4302 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group C | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Toll-like and Il-1 receptors | TLR2 | Toll-like receptor 2 | O60603 | CHEMBL4163 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | FABP2 | Fatty acid binding protein intestinal | P12104 | CHEMBL4879 |
Unclassified | FABP4 | Fatty acid binding protein adipocyte | P15090 | CHEMBL2083 |
Unclassified | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0019433; triglyceride catabolic process | 2.737E-10 | 1.986E-06 | FABP2, FABP3, FABP4, FABP5 |
BP | GO:0051179; localization | GO:0015908; fatty acid transport | 3.301E-06 | 4.492E-03 | FABP3, PPARA, PPARD |
BP | GO:0050896; response to stimulus | GO:0001666; response to hypoxia | 3.775E-06 | 4.637E-03 | LMNA, PPARA, PPARD, TLR2 |
MF | GO:0005488; binding | GO:0036041; long-chain fatty acid binding | 1.059E-05 | 1.003E-02 | FABP3, PPARD |
MF | GO:0140110; transcription regulator activity | GO:0004879; nuclear receptor activity | 2.244E-04 | 1.265E-01 | PPARA, PPARD |
MF | GO:0060089; molecular transducer activity | GO:0003707; steroid hormone receptor activity | 3.257E-04 | 1.509E-01 | PPARA, PPARD |
CC | Unclassified; | GO:0106003; amyloid-beta complex | 5.115E-03 | 5.682E-01 | TLR2 |
CC | GO:0044464; cell part | GO:0009986; cell surface | 2.483E-02 | 1.000E+00 | ABCB1, TLR2 |
CC | GO:0044421; extracellular region part | GO:0070062; extracellular exosome | 3.059E-02 | 1.000E+00 | ABCB1, FABP3, FABP4, FABP5 |
CC | GO:0044464; cell part | GO:0035578; azurophil granule lumen | 4.162E-02 | 1.000E+00 | FABP5 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 1.125E-13 | 3.936E-12 | FABP2, FABP3, FABP4, FABP5, PPARA, PPARD |
09160 Human Diseases | 09165 Cardiovascular diseases | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 3.282E-02 | 8.401E-02 | LMNA |
09160 Human Diseases | 09165 Cardiovascular diseases | hsa05414 | Dilated cardiomyopathy | 3.979E-02 | 8.401E-02 | LMNA |
09160 Human Diseases | 09165 Cardiovascular diseases | hsa05410 | Hypertrophic cardiomyopathy (HCM) | 3.674E-02 | 8.401E-02 | LMNA |
09150 Organismal Systems | 09152 Endocrine system | hsa04922 | Glucagon signaling pathway | 4.455E-02 | 8.401E-02 | PPARA |
09160 Human Diseases | 09167 Infectious diseases | hsa05146 | Amoebiasis | 4.412E-02 | 8.401E-02 | TLR2 |
09160 Human Diseases | 09162 Immune diseases | hsa05323 | Rheumatoid arthritis | 3.979E-02 | 8.401E-02 | TLR2 |
09150 Organismal Systems | 09151 Immune system | hsa04620 | Toll-like receptor signaling pathway | 4.671E-02 | 8.401E-02 | TLR2 |
09160 Human Diseases | 09167 Infectious diseases | hsa05142 | Chagas disease (American trypanosomiasis) | 4.585E-02 | 8.401E-02 | TLR2 |
09160 Human Diseases | 09166 Endocrine and metabolic diseases | hsa04931 | Insulin resistance | 4.800E-02 | 8.401E-02 | PPARA |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|